|Title of Invention||
"BLOOD COMPONENT SEPERATION METHOD AND APPARATUS"
|Abstract||A vaccine which contains at least one immunogenic compound comprising a peptide or a peptide derivative thereof, wherein said peptide is of a size comprised between 5 and 40 amino acids, originating from a cytokine, wherein at least one of its amino acids comprises at least one of its atoms separated by a distance d of less than 5 angstroms from an atom of the receptor corresponding to said cytokine, the spacing d being evaluated on the basis of structural data with the exception of the peptides comprised between the 2nd and 3rd cysteine of hRANTES, MIP Iα AND MIP Iβ; and wherein said immunogenic compound does not comprise other epitopes of said cytokine and wherein said immunogenic compound is capable of generating in a subject antibodies recognizing the native cytokine.|
|Full Text||Blood Component Separation Method and Apparatus
The following invention relates generally to instrumentalities and methodologies in blood component separation techniques. More specifically/ the instant invention is directed to a method and apparatus for collecting a blood sample and subsequently separating the collected sample into the blood components for individual storage or
Blood collection is always important, particularly in times of emergency (immediate use), but whole blood may only be stored for about 30 days before it is "outdated". For long term storage, the ability to separate the whole blood into its major components (white blood cells, platelets, red blood cells and plasma) is of paramount importance because the long term storage conditions for each component is different in terms of temperature and storage media. The most important component separations occurring after collection is the separation of red blood cells (RBC), white blood cells (WBC), platelets, and plasma from one another. Within the WBC it is sometimes important to separate the granulocytes from the lymphocytes. After separation and extraction of particular components, a fraction of the blood may be returned to the patient
It is possible to separate the various components of whole blood either under or after centrifugation, due to their differing densities. Some prior art methods, such as that in U.S. Patent 4,120,44s, utilize a chamber connected to a centrifuge. The centrifuged blood separates in the chamber, and a plurality of collection means are positioned at various locations in the chamber corresponding to the areas where each component congregates, which is density-dependent
Disclosure of Invention
The present invention comprises a bag set that may be used to collect a whole blood sample from a source, then placed into a centrifuge for component separation. The whole blood collection bag, which contains an anticoagulant such as CPD, ACD or
CPD-A, contains one outlet port connected to a plurality of component collection bags. Each component collection bag has a separate line leading from the whole blood collection bag, and each line can be clamped, tube-sealed and separated from the whole blood collection bag once a particular component bag has been filled.
In practice, die blood is collected into the whole blood collection bag and the input line is clamped, sealed off, and separated from the whole blood collection bag. The whole blood collection bag hangs in a damshell-style container that closely contacts the bag at the bottom end, and is adapted to fit in a centrifuge cup. The centrifuge is operated at varying G-forces to optimally separate the components. Once the components are separated in the whole blood collection bag, a driver motor is engaged to open a metering valve on the line leading from the collection bag to a bag that will contain the densest component. This allows the densest component to fill its particular storage bag.
Complete collection of the first component is indicated by an optical sensor that is present in the clamshell container. The driver motor, directed by the sensor, automatically closes the metering valve on the line, terminating collection of that particular component. The driver motor then further engages the metering valve to allow collection of the next component through a second output line connecting the metering valve and the second storage bag- The process may sequentially continue until all desired components are collected in separate storage bags: red blood cells, white blood cells (lymphocytes and granulocytes)/ platelets, and plasma.
Once collected, each storage bag may be sealed off and separated from the whole blood collection bag. Any necessary preservatives or additives may be introduced through the collection lines before processing or storing.
The industrial applicability of this invention shall be demonstrated through discussion of the following objects of the invention.
Accordingly, it is a primary object of die present invention to provide a new and novel device and method for separating the components of whole blood for subsequent storage or use.
It is a further object of the present invention to provide a device and method as characterized above in which separation may be accomplished entirely by machine during a single centrifugation nm without the considerable handling and multiple centrifugation runs typically practiced in a blood bank.
It is a further object of the present invention to provide a device and method as characterized above in which the separation apparatus is self-contained to simplify the operation.
Viewed from a first vantage point/ it is an object of the present invention to provide a bag set, comprising, in combination: a centrifuge bag leading to first and second bags; an inlet to allow blood into said centrifuge bag; conduits leading from said centrifuge bag to said red and white blood cell bags; and valve means operating under machine control to admit blood fractions to said first and second bags.
Viewed from a second vantage point, it is an object of the present invention to provide a system for separating blood cells, comprising, in combination: a centrifuge; a bag set having plural interconnected bags; and a bag set container contoured to be received in said centrifuge, said container including means to selectively provide access between bags within said bag set
Viewed from a third vantage point it is an object of the present invention to provide a method for separating blood cells, the steps including: centrifuging a mixture of blood cells to cause stratification, the stratification producing a first cell layer and a second cell layer; opening a conduit leading to a first cell bag; centrifuging the first cell layer into the first cell bag; dosing the conduit to the first cell bag; opening a conduit leading to a second cell bag; and centrifuging the second cell layer to the second cell bag.
These and other objects will be made manifest when considering the following detailed specification when taken in conjunction with the appended drawing figures.
Brief Pgyqjptiflp Of The Drawings
Figure 1 depicts the bag set of the present invention-Figures 2A and 2B depict the clamshell container before insertion of the bag set. Figures 3A-3C depict the clamshell bag holder after insertion of the bag set. Figures 4A and 4B depict the bag set in the chamber before centrifugation-Figures 5A and 5B depict the bag set in the chamber after centrifugatian. Figures 6A and 6B depict the harvesting of the greater-density component Figures 7A and 7B depict the harvesting of the lesser-density component. Figures 8A and 8B depict the separate collection lines of the bag set after disconnection from the collection bag.
Figures 9A-9C depict the operating positions of the metering valve. Figure 10 is a flowchart of the preferred process.
Figure 11 illustrates the separation of whole blood components in graphical form.
Best Modefe) for carrying Out the Invention
Considering the drawings, wherein like reference numerals denote like parte throughout the various drawing figures/ reference numeral 10 as shown in FIG. 1 is directed to the bag set according to the present invention.
Referring to FIG. 1, the bag set 10 includes a whole blood collection bag 2, a red blood cell (RBC) bag 4, and a freezing bag 6 for the collection and storage of white blood cells. The collection bag 2 is supplied through an inlet line 12, preferably through a phlebotomy needle 8. The collection bag 2 has an outlet 26, which directs output into a three-way metering valve 20 through a spike 30 (which is inserted into outlet 26) which is connected to an outlet line 32. The operation positions of the metering valve 20 are shown in FIGS. 9A-9C Two supply lines 24a,24b lead from the metering valve 20 to the RBC bag 4 and the freezing bag 6, respectively. RBC supply line 24a has an optional HES inlet 14 for the introduction of a sedimenting agent such as hydroxyethyl starch (HES) into the system- The freezing bag supply line 24b has an optional cryoprotectant inlet 16 for the introduction of cryoprotectant into the system. The HES inlet 14 and the cryoprotectant inlet 16 are each equipped with a filter 18, preferably a 0.2p filter, to, inter alia, prevent contamination from pathogens in the outside air and to allow venting of air from the freezing bag and tubing. The supply lines 24a,24b and the inlet line 12 may each be heat sealed and separated from the bag set 10. All lines are equipped with line clamps 22 that may be closed to prevent fluid passage when desired. If other components are to be separated, the bag set 10 may include additional bags 200, and the metering valve 20 may be modified to accommodate the additional bags 200.
Initially, the collection bag 2 is filled with an anticoagulant, such as CPD (citrate, phosphate, and dextrose). The metering valve 20 begins in the closed position (FIG 9A). All clamps 22 are closed/ with the exception of the damp 22 on the inlet line 12. Blood, preferably whole, placental, or umbilical cord blood, is obtained from a source through the phlebotomy needle 8 or other appropriate inlet which feeds into the collection bag 2 through the inlet line 12 The inlet line 12 is then clamped, heat sealed, and separated from the bag set 10. The clamps 22 on the HES inlet line 14 are opened, and HES is introduced through the HES inlet 14 into bag 2, The line leading to the HES
inlet 14 is then damped, heat sealed, and removed. Alternatively, the HES can be introduced into the bag 2 earlier, as, for example, during manufacture
At this point, the bag set 10 is placed in a clamshell bag holder 50, shown in FIGS. 3A-3C Referring to FIGS. 2AJ1&, the bag holder 50 includes hooks 60 that engage the loops 28 on the collection bag 2* The interior of the bag holder 50 is shaped to receive the collection bag 2, having a bag holding wall 152, a bag-supporting wall 154, and straight sidewalls 156 near the top of the bag holder 50, which intersect with angled walls 156 at the bottom of the collection bag 2. The angled walls 156 terminate at the bottom of the bag-holding wall 152 in an outport 160 dimensioned to receive the outlet 26 of the collection bag 2. On the bag-supporting wall 154, the angled walls 158 terminate at an angled point 162. The sidewalls 156,158 help to cradle the collection bag 2 loosely at the top (near the loops 28) and more tightly at the bottom (near the outlet 26). Closer tolerance near the bottom of bag 2 is desired to minimize disturbing the contents of the bag after sedimentation, The metering valve 20 is connected to a motor driver 56 in the bag holder 50. The motor driver 56 is connected to a software-controlled wireless control chip module 54 powered by a rechargeable battery 52. A port 64 is provided to utilize a battery charger. The motor driver 56 controls the operation oi the metering valve 20 while the bag set 10 is mounted in the bag holder 50. One or more optical sensors 58 (e.gv FIGS. 2A,2B) positioned near the collection bag outlet 26 and/or located on the bag holder 50 triggers the proper time for the motor driver 56 to close the metering valve 20 after each fraction is harvested. Alternatively, an optical sensor 58 (FIG. 1) may be located just upstream of the metering valve 20 to allow greater control over the harvest of each component by "reading" strata change closest to the metering valve 20. The bag holder 50, when dosed, is adapted to fit into a centrifuge cup 66 dimensioned to reside within a conventional centrifuge 100 (FIG. 4A). The RBC bag 4 and the freezing bag 6 are cradled in the bottom of the bag holder 50 in separate recesses 62a,62b (FIGS. 2A,2B) of the bag holder 50.
The bag set 10 in the centrifuge cup 66 may be subjected to more than one G-torce in order to achieve the optimum stratification of components (FIGS. 5AJ5B). Tlie motor driver 56 then operates the metering valve 20 to open and allow access to supply line 24a for the harvest of red blood cells, at an optimum G-force, into bag 4- The motor driver 56 doses the metering valve 20 when the optical sensor 58 indicates that the red blood cells are harvested (FIGS. 6A,6B). The next fraction, which includes white cells and/or platelets, is then harvested from the collection bag 2; the motor driver 56 opens the metering valve 20 to allow access to supply line 24b (FIG. 9C) leading to bag
6 for the next harvest As shown in FIGS. 7A,7B, during the harvest (WBC) into the freezing bag 6, air in the supply line adds to air already in the freezing bag 6, producing an air bubble 70, which is useful to assist the proper mixing of the WBC and/or platelet9 with the cryoprotectant. The motor driver 56 then closes the metering valve 20, as shown in FIG. 9A, and the centrifuge 100 is allowed to stop.
The bag holder 50 is removed from the centrifuge cup 66 and opened, and the bag set 10 is removed, with the motor driver disconnected from the metering valve 20. Each supply line 24a,24b is clamped, heat sealed, and removed from the collection bag 2 (FIGS. 8A,8B). Any additional bags 200 (FIG. 1) may be similarly removed.
After the supply line 24b connected to the freezing bag 6 is disconnected, a cryoprotectant may be introduced into the component in the freezing bag 6 through cryoprotectant inlet 16. The air bubble 70 in the freezing bag 6 allows the cryoprotectant to be thoroughly mixed with the collected component. After mixing, the air bubble 70 is expelled through the filter 18 of the cryoprotectant inlet 16. The component is then prepared for storage by heat-sealing the tubing and removing the bag 6 downstream of the cryoprotectant inlet 16.
Preferably, each line (the inlet line 12 and the supply lines 24a,24b) is oriented to allow access to a sampling site 34 near the collection or storage bags. Thus, a sample of the blood or fluid in the line may be taken without disturbing the bulk of the collected component
FIG. 11 depicts the separation of whole blood components as a function of time. Under centrifugation, each fraction stratifies in the collection bag 2 as a function of its density. The overlapping areas 205 indicate the area in the separation along each strata line in the collection bag 2. As centrifugation continues, the boundary of each fraction becomes more clearly defined; thus, the area 205 decreases and each fraction is more completely harvested. Thus, the centrifugation strategy combines separation by density, die time involved for stratification, centrifuge force, and boundary layer clarity. Decisions on harvesting will vary based on these tradeoffs as a function of the constituent of greatest value and its desired purity.
It is appreciated that while the instant invention is preferably used in the separation of blood components, Ae separation techniques and apparatus are suitable for separation of other fluids. The software programmed into the control chip module may cause the motor driver to open and close the valve many times, thereby throttling the valve during strata delivery. Also by varying time increments during a harvest procedure, precise cut-offe between the cell components can be achieved in order to
reduce the mixing between cell types that may occur as a result of the "toroidal" (Coriolis) effect during removal of the blood component from bag 2 and may be modified for the separation of other fluids or to compensate for various hardware conditions, such as uneven centrifuge loading. Moreover, having thus described the invention, h should be apparent that numerous structural modifications and adaptations may be resorted to without departing from the scope and fair meaning of the instant invention as set forth hereinabove and as described hereinbelow by the claims.
[received by the International Bureau on I5 September 2003 (15.09.03);
original claims 1,2.3,4 and 6 amended; new claim S added;
remaining claims unchanged (2 pages)]
Claim 1 - A bag set for use in a conventional centrifuge, comprising, in combination:
a centrifuge bag leading to first and second bags;
an inlet to allow blood into said centrifuge bag;
conduits leading from said centrifuge bag to said first and second bags; and
valve means operating under machine control to admit blood fractions to said first and second bags, wherein red blood cells are admitted to one said bag and whit blood cells are admitted to another said bags providing a red blood cell bag and a white blood cell bag.
Claim 2 ~ The bag set of claim 1 further including:
a holder for said bag set which ensconces said centrifuge bag and said red and white blood cell bags, said valve means in said bag set and communicating with said holder and operatively coupled to a motor located on said holder, said holder adapted to fit an opening in a conventional centrifuge; and
a sensor in said holder, the sensor monitoring for demarking a transition from red to white blood cells, whereupon said valve means diverts from said red blood cell bag to said white blood cell bag via said motor.
Claim 3 * A system for separating blood cells, comprising, in combination:
a conventional centrifuge;
a bag set having plural interconnected bags; and
a bag set container contoured to be received in said conventional centrifuge, said container including means to selectively provide access between bags within said bag set.
Claim 4 - The system of claim 3 wherein said bag set includes a first, second, and third bag, said second and third bags selectively communicating with said first bag, sensing means monitoring said first bag and means to direct flow to said second and third bags responsive to said sensing means.
Claim 5-The system of claim 4 wherein said sensing means are located in a bag set holder dimensioned to reside in said centrifuge,
said directing means including a drive motor in said holder and a valve disposed on a passageway of said bag set.
Claim 6 - A method for separating blood cells using a conventional centrifuge/ the steps including:
collecting a mixture of blood cells in a collection bag;
ensconcing said collection bag in a bag set holder, said bag set holder adapted to fit openings in a conventional centrifuge;
centrifuging said mixture of blood cells to cause stratification, the stratification producing a first ceil layer and a second cell layer;
opening a conduit leading to a first cell bag;
centrifuging the first cell layer into the first cell bag;
closing the conduit to the first cell bag;
opening a conduit leading to a second cell bag; and
centrifuging the second cell layer to the second cell bag. Claim 7 - The method of claim 6 further including the steps of:
sensing the stratification; and
directing a motor to switch a valve from said first bag to said second bag, based on completion of centrifuging the first cell layer into the first cell bag.
Claim 8 - A method of separating blood components in a conventional centrifuge/ the steps including:
collecting a mixture of blood cells in a bag set, said bag set having plural bags;
ensconcing said bag set in a holder, said holder adapted to fit into a conventional centrifuge;
centrifuging said mixture of blood cells to cause stratification, said stratification providing a plurality of cell layers;
activating a sensor in said holder to sense boundaries of said cell layer;
centrifuging each cell layer into a separate one of said plural bags, wherein said sensor signals an end to each subsequent centrifuging step by indicating said boundaries.
9. A bag set for use in a conventional centrifuge substantially as herein described with reference to the accompanying drawings.
|Indian Patent Application Number||2520/CHENP/2004|
|PG Journal Number||35/2013|
|Date of Filing||08-Nov-2004|
|Name of Patentee||THERMOGENESIS CORP|
|Applicant Address||2711 CITRUS ROAD RANCHO CORDOVA CALIFORNIA 95742|
|PCT International Classification Number||B01D21/26|
|PCT International Application Number||PCT/US03/08830|
|PCT International Filing date||2003-04-08|